|
|
Article: DRUG TO SHAKE UP INSOMNIA MARKET SEPRACOR SAYS LUNESTA WILL KEEP USERS ASLEEP LONGER THAN RIVALS CAN
- Article from:
- The Boston Globe (Boston, MA)
- Article date:
- April 2, 2005
- Author:
CopyrightCopyright 2005 The Boston Globe. Provided by ProQuest LLC. (Hide copyright information)
|
Sepracor Inc. yesterday said it plans to begin selling its long-
awaited Lunesta sleeping pill next week, setting the stage for a
marketing war that will wake up the insomnia market.
Sepracor, of Marlborough, said the Drug Enforcement Agency on
Monday will publish rules to let it begin selling its prescription
drug Lunesta, and that more than 40,000 pharmacies have already
placed orders.
Lunesta's launch will mark an important moment in the $3.5 billion
sleeping pill market, now dominated by the drug Ambien made by Sanofi-
Aventis Group and King Pharmaceuticals' Sonata.
The Food and Drug Administration will let Sepracor claim that
Lunesta will keep consumers asleep longer than its two main ...